Targeting Factor IX levels in patients with. Haemophilia B who are undergoing surgery is ‘complex and suboptimal’ but the incidence of bleeding complications is low – so say specialists from the UK and the Netherlands (Haemophilia 2018;April 29. DOI: 10.1111/hae.13469).

The study assessed outcomes in 255 minor and major surgical carried out between 2000 and 2015 procedures in 118 patients (median age 40). Factor IX levels were <0.05 IU/ml-1. Within the first 24 hours after surgery, 60% of FIX levels were below the target of 0.80 – 1.00 IU/ml-1 by a median of 0.22 IU/ml-1. At 6 days, when the target range was 0.30 – 0.50 IU/ml-1, this figure had fallen to 9%, with 59% of levels above the target range by a median of 0.19 IU/ml-1. Clinically relevant bleeding complications – defined as requiring a second surgical intervention or red cell transfusion – affected 7 procedures (2.7%).

The authors question the value of perioperative FIX levels recommended by management guidelines when the risk of bleeding complications is low even when targets are not met.

Contact us

Member Log in

Not a member? Register here